Today, U.S. Representatives Randy Weber and Chris Pappas introduced the United States-Israel Bilateral Innovation for Research and Development in Health Act of 2025. The legislation aims to enhance collaboration between the two nations in medical innovation.
The BIRD Health Act is designed to strengthen U.S.-Israel partnerships by creating a dedicated program within the Binational Industrial Research and Development Foundation. This initiative is expected to bolster domestic supply chains and reduce dependency on foreign nations for essential medical products by leveraging Israel’s biotech ecosystem and America’s research capabilities.
“The United States and Israel share one of the strongest, most enduring alliances in the world, and it just makes sense to join forces in advancing life-saving health technologies that benefit both our nations,” said Rep. Weber. “The BIRD Health Act of 2025 builds on our shared strengths to support cutting-edge medical innovation, strengthen supply chains, and improve health outcomes for American families.”
Rep. Pappas added, “U.S. and Israeli doctors, scientists, and researchers are leading the world in groundbreaking medical advancements, including regenerative medicine, disease prevention, and cancer research.” He emphasized that the new program would reinforce bilateral cooperation to address health challenges through innovative solutions.
The bill outlines support for joint research efforts in various fields such as medical devices, digital health, diagnostics, vaccines, biotechnology, manufacturing partnerships for critical medicines production within the U.S., fostering innovation ecosystems for startups and clinical trials, as well as establishing data-sharing protocols to protect patient privacy.
###
